What does Wes Streeting's exit mean for the NHS modernisation bill?

What does Wes Streeting's exit mean for the NHS modernisation bill?

May 22, 2026 · 37 min · Episode 80

About this episode

The episode discusses the implications of Wes Streeting's resignation on the NHS Modernization Bill and explores a significant name change in women's healthcare.

It has been a tumultuous time in UK health politics. UK Health Minister ,Wes Streeting, has freshly resigned. What does this mean for his newly introduced NHS Modernization Bill as it heads through Parliament? Together with Hugh Alderwick, Director of Policy and Research at the Health Foundation, we unpack the bill's sweeping centralization of power, the abolition of NHS England, and the contentious role for US tech firm Palantir in the new NHS. And, we explore a major milestone for women's healthcare. A condition affecting an estimated 170 million women globally has officially been renamed from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS). Rachel Morman, Chair of the PMOS charity Verity, joins us to explain why dropping "cysts" from the name is a vital step toward recognizing this as a complex, multi-system condition, and how this co-designed change will fundamentally reshape diagnosis, treatment, and future research. Further reading: Health Bill brings NHS management back into government PMOS: What's in a name? Everything PCOS name change to PMOS must be managed to avoid confusing patients, says expert

People in this episode

Guests: Hugh Alderwick, Rachel Morman

Topics covered

Keywords

Mentioned in this episode

Organizations: NHS, Health Foundation, PMOS charity Verity, Palantir

Books & works: Polycystic Ovary Syndrome, Polyendocrine Metabolic Ovarian Syndrome

Places: UK

More episodes of Medicine and Science from The BMJ

Explore listener stats, chart rankings, contacts and more on the Medicine and Science from The BMJ podcast page.